Prawo i regulacje · 29/09/2017

Bellwyck Clinical Services Seeks DEA License to Import Controlled Substances

Bellwyck Clinical Services has submitted an application to become a licensed importer of controlled substances in the United States. The application is currently under review by the U.S. Drug Enforcement Administration (DEA).